Acadia Pharmaceuticals (ACAD) EBIT Margin (2010 - 2026)
Acadia Pharmaceuticals (ACAD) recorded quarterly EBIT Margin of 1.72% in Q1 2026, up 91.58% quarter-over-quarter from 20.46% in Q4 2025, and down 962.0% on a YoY basis from 0.2% in Q1 2025.
Acadia Pharmaceuticals (ACAD) EBIT Margin (2010 - 2026) Analysis & Trends
Acadia Pharmaceuticals' EBIT Margin history runs 17 years deep, the most recent figure standing at 1.72% for Q1 2026.
- In Q1 2026, EBIT Margin fell 962.0% year-over-year to 1.72%; the TTM figure through Mar 2026 stood at 0.49% (down 2308.0% YoY), while the FY2025 annual figure was 2.74%, down 2136.0% from the prior year.
- EBIT Margin was 1.72% for Q1 2026 at Acadia Pharmaceuticals, up from 20.46% in the prior quarter.
- In the past five years, EBIT Margin ranged from a high of 59.13% in Q4 2024 to a low of 97.88% in Q1 2022.
- Historically, EBIT Margin has averaged 7.84% across 5 years, with a median of 1.84% in 2023.
- The sharpest annual moves came in 2022 and 2023: EBIT Margin sank 10304 bps in 2022, then soared 5264 bps in 2023.
- A 5-year view of EBIT Margin shows it stood at 33.75% in 2022, then surged by 145 bps to 15.12% in 2023, then soared by 291 bps to 59.13% in 2024, then slumped by 135 bps to 20.46% in 2025, then jumped by 92 bps to 1.72% in 2026.
- The last three EBIT Margin figures came in at 1.72% (Q1 2026), 20.46% (Q4 2025), and 12.83% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -6.43% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 38.10% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Acadia Pharmaceuticals | 3.68 Bn | 2.83 Bn | 243.27 Mn | -1.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.72% |
| Dec 31, 2025 | -20.46% |
| Sep 30, 2025 | 12.83% |
| Jun 30, 2025 | 12.24% |
| Mar 31, 2025 | 7.90% |
| Dec 31, 2024 | 59.13% |
| Sep 30, 2024 | 12.64% |
| Jun 30, 2024 | 12.58% |
| Mar 31, 2024 | 7.39% |
| Dec 31, 2023 | 15.12% |
| Sep 30, 2023 | -27.29% |
| Jun 30, 2023 | 1.84% |
| Mar 31, 2023 | -45.23% |
| Dec 31, 2022 | -33.75% |
| Sep 30, 2022 | -23.61% |
| Jun 30, 2022 | -25.01% |
| Mar 31, 2022 | -97.88% |
| Dec 31, 2021 | 69.29% |
| Sep 30, 2021 | -11.63% |
| Jun 30, 2021 | -37.93% |